Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017

Matthew Harrison Downgraded (BLUE) to Sell on, Oct 2nd, 2017


//stocks-investing.news-articles.net/content/201 .. son-downgraded-blue-to-sell-on-oct-2nd-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "bluebird bio, Inc." (BLUE) to Sell on, Oct 2nd, 2017.

Matthew has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Initiated at Hold and Held Target at $102 on, Thursday, August 17th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017
  • Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Gena Wang of "Barclays" Initiated at Buy and Held Target at $151 on, Thursday, September 7th, 2017
  • Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017

Publication Contributing Sources